KBC Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Sell |
1,807
-1,735
| -49% | -$27.8K | ﹤0.01% | 1702 |
|
|
2025
Q1 | $61K | Buy |
3,542
+443
| +14% | +$7.63K | ﹤0.01% | 1728 |
|
|
2024
Q4 | $77K | Buy |
3,099
+1,163
| +60% | +$28.9K | ﹤0.01% | 1693 |
|
|
2024
Q3 | $55K | Buy |
1,936
+612
| +46% | +$17.4K | ﹤0.01% | 1664 |
|
|
2024
Q2 | $35K | Hold |
1,324
| – | – | ﹤0.01% | 1779 |
|
|
2024
Q1 | $43K | Hold |
1,324
| – | – | ﹤0.01% | 1632 |
|
|
2023
Q4 | $56K | Buy |
1,324
+406
| +44% | +$17.2K | ﹤0.01% | 1443 |
|
|
2023
Q3 | $35K | Buy |
+918
| New | +$35K | ﹤0.01% | 1706 |
|